Open Access

HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs

Retraction in: /10.3892/ol.2024.14434

  • Authors:
    • Li Xiong
    • Shuqing Zhen
    • Qionghua Yu
    • Zuojiong Gong
  • View Affiliations

  • Published online on: June 20, 2017     https://doi.org/10.3892/ol.2017.6433
  • Pages: 2141-2146
  • Copyright: © Xiong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Exosomal miRNAs are emerging as mediators of the interaction between mast cells (MCs) and tumor cells. The exosomal miRNAs can be internalized by liver cancer cells to inhibit cell metastasis. We explored the interaction between MCs and hepatocellular carcinoma (HCC) cells. We used hepatitis C virus E2 envelope glycoprotein (HCV‑E2) to stimulate MCs and harvest MCs‑derived exosomes to detect the miRNAs and changes of exosomal miRNAs before and after stimulation. Through miRNA microarray analysis, we identified 19 differentially expressed miRNAs in exosomes derived from MCs with or without HCV‑E2 treatment. HCV‑E2 not only increased the level of miRNA‑490 in MCs and their secreted exosomes but also increased the levels of miRNA‑490 in recipient HepG2 cells, which ultimately inhibited the ERK1/2 pathway. The transfection of antagomiR‑490 significantly decreased the levels of miR‑490 in MCs, MCs‑derived exosomes, and recipient HepG2 cells and increased migration of HepG2, indicating that miR‑490 is involved in the regulation of HepG2 cell migration. The present study suggests that MCs can inhibit HCC cell metastasis by inhibiting the ERK1/2 pathway by transferring the exosomal shuttle microRNAs into HCC cells, which provides new insights for the biological therapy of HCC induced by hepatitis C.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 14 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xiong L, Zhen S, Yu Q and Gong Z: HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs Retraction in /10.3892/ol.2024.14434. Oncol Lett 14: 2141-2146, 2017.
APA
Xiong, L., Zhen, S., Yu, Q., & Gong, Z. (2017). HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs Retraction in /10.3892/ol.2024.14434. Oncology Letters, 14, 2141-2146. https://doi.org/10.3892/ol.2017.6433
MLA
Xiong, L., Zhen, S., Yu, Q., Gong, Z."HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs Retraction in /10.3892/ol.2024.14434". Oncology Letters 14.2 (2017): 2141-2146.
Chicago
Xiong, L., Zhen, S., Yu, Q., Gong, Z."HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs Retraction in /10.3892/ol.2024.14434". Oncology Letters 14, no. 2 (2017): 2141-2146. https://doi.org/10.3892/ol.2017.6433